Erratum: A multicenter study to evaluate ceftaroline breakpoints: Performance in an area with high prevalence of methicillin-resistant Staphylococcus aureus sequence type 5 lineage (J Clin Microbiol (2019) 57:9 (e00798-19) DOI: 10.1128/JCM.00798-19)

Ayesha Khan, Lina M. Rivas, Maria Spencer, Rodrigo Martinez, Marusella Lam, Pamela Rojas, Lorena Porte, Francisco Silva, Stephanie Braun, Francisca Valdivieso, Margareta Mϋlhauser, Mónica Lafourcade, William R. Miller, Patricia García, Cesar A. Arias, Jose M. Munita

Research output: Contribution to journalComment/debatepeer-review

Abstract

The following funding information and acknowledgments should have appeared in the article. Jose M. Munita was supported by Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) (grant number FONDECYT 1171805) and the ANID Millenium Science Initiative, MICROB-R, NCN17-081, Government of Chile. Cesar A. Arias was supported by the National Institute of Allergy and Infectious Diseases (NIAID) (grant numbers K24-AI121296, R01AI093749, R01AI134637, and R21/R33 AI121519).

Original languageEnglish (US)
Article numbere00734-21
JournalJournal of Clinical Microbiology
Volume59
Issue number6
DOIs
StatePublished - Jun 2021

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint

Dive into the research topics of 'Erratum: A multicenter study to evaluate ceftaroline breakpoints: Performance in an area with high prevalence of methicillin-resistant Staphylococcus aureus sequence type 5 lineage (J Clin Microbiol (2019) 57:9 (e00798-19) DOI: 10.1128/JCM.00798-19)'. Together they form a unique fingerprint.

Cite this